Phoenix Biotech Acquisition (PBAXW) Competitors $0.02 0.00 (-3.55%) As of 08/15/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock PBAXW vs. ANSCW, ANSCU, AFJKU, ALCYW, ALCYU, ATMCW, ATMCU, ATMVU, AEAEW, and AEAEUShould you be buying Phoenix Biotech Acquisition stock or one of its competitors? The main competitors of Phoenix Biotech Acquisition include Agriculture & Natural Solutions Acquisition (ANSCW), Agriculture & Natural Solutions Acquisition (ANSCU), Aimei Health Technology (AFJKU), Alchemy Investments Acquisition Corp 1 (ALCYW), Alchemy Investments Acquisition Corp 1 (ALCYU), AlphaTime Acquisition (ATMCW), AlphaTime Acquisition (ATMCU), AlphaVest Acquisition (ATMVU), AltEnergy Acquisition (AEAEW), and AltEnergy Acquisition (AEAEU). These companies are all part of the "shell companies" industry. Phoenix Biotech Acquisition vs. Its Competitors Agriculture & Natural Solutions Acquisition Agriculture & Natural Solutions Acquisition Aimei Health Technology Alchemy Investments Acquisition Corp 1 Alchemy Investments Acquisition Corp 1 AlphaTime Acquisition AlphaTime Acquisition AlphaVest Acquisition AltEnergy Acquisition AltEnergy Acquisition Phoenix Biotech Acquisition (NASDAQ:PBAXW) and Agriculture & Natural Solutions Acquisition (NASDAQ:ANSCW) are both financial services companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability, risk and media sentiment. Is PBAXW or ANSCW more profitable? Company Net Margins Return on Equity Return on Assets Phoenix Biotech AcquisitionN/A N/A N/A Agriculture & Natural Solutions Acquisition N/A N/A N/A Which has better earnings & valuation, PBAXW or ANSCW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPhoenix Biotech AcquisitionN/AN/AN/AN/AN/AAgriculture & Natural Solutions AcquisitionN/AN/AN/AN/AN/A Does the media favor PBAXW or ANSCW? In the previous week, Phoenix Biotech Acquisition's average media sentiment score of 0.00 equaled Agriculture & Natural Solutions Acquisition'saverage media sentiment score. Company Overall Sentiment Phoenix Biotech Acquisition Neutral Agriculture & Natural Solutions Acquisition Neutral SummaryPhoenix Biotech Acquisition and Agriculture & Natural Solutions Acquisition tied by winning 0 of the 0 factors compared between the two stocks. Get Phoenix Biotech Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for PBAXW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PBAXW vs. The Competition Export to ExcelMetricPhoenix Biotech AcquisitionShell Companies IndustryFinancial SectorNASDAQ ExchangeMarket CapN/A$485.96M$6.42B$9.64BDividend YieldN/A5.35%4.17%4.09%P/E RatioN/A0.8214.2725.12Price / SalesN/A689.011,822.43157.26Price / CashN/A178.7349.1228.45Price / BookN/A66.153.565.94Net IncomeN/A-$141.08M$1.23B$265.56M7 Day PerformanceN/A0.10%0.22%0.95%1 Month PerformanceN/A0.19%1.64%2.47%1 Year PerformanceN/A53.70%26.49%20.24% Phoenix Biotech Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PBAXWPhoenix Biotech AcquisitionN/A$0.02-3.6%N/AN/A$0.00N/A0.00N/AGap DownHigh Trading VolumeANSCWAgriculture & Natural Solutions AcquisitionN/A$0.24+4.3%N/A+53.2%$0.00N/A0.00N/APositive NewsGap DownHigh Trading VolumeANSCUAgriculture & Natural Solutions AcquisitionN/A$11.00-5.5%N/AN/A$0.00N/A0.00N/APositive NewsAFJKUAimei Health TechnologyN/A$11.25+0.4%N/AN/A$0.00N/A0.00N/AALCYWAlchemy Investments Acquisition Corp 1N/A$0.13flatN/AN/A$0.00N/A0.00N/APositive NewsGap UpALCYUAlchemy Investments Acquisition Corp 1N/A$11.41flatN/AN/A$0.00N/A0.00N/APositive NewsATMCWAlphaTime AcquisitionN/A$0.06+5.8%N/AN/A$0.00N/A0.00N/APositive NewsATMCUAlphaTime AcquisitionN/A$12.87-1.0%N/AN/A$0.00N/A0.00N/APositive NewsATMVUAlphaVest AcquisitionN/A$12.00+6.1%N/AN/A$0.00N/A0.00N/APositive NewsGap UpAEAEWAltEnergy AcquisitionN/A$0.05flatN/AN/A$0.00N/A0.003AEAEUAltEnergy AcquisitionN/A$10.82flatN/AN/A$0.00N/A0.003 Related Companies and Tools Related Companies ANSCW Competitors ANSCU Competitors AFJKU Competitors ALCYW Competitors ALCYU Competitors ATMCW Competitors ATMCU Competitors ATMVU Competitors AEAEW Competitors AEAEU Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PBAXW) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phoenix Biotech Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Phoenix Biotech Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access